|  Help  |  About  |  Contact Us

Publication : miRNA-130a regulates C/EBP-ε expression during granulopoiesis.

First Author  Larsen MT Year  2014
Journal  Blood Volume  123
Issue  7 Pages  1079-89
PubMed ID  24398327 Mgi Jnum  J:208687
Mgi Id  MGI:5564831 Doi  10.1182/blood-2013-08-523233
Citation  Larsen MT, et al. (2014) miRNA-130a regulates C/EBP-epsilon expression during granulopoiesis. Blood 123(7):1079-89
abstractText  CCAAT/enhancer binding protein-epsilon (C/EBP-epsilon) is considered a master transcription factor regulating terminal neutrophil maturation. It is essential for expression of secondary granule proteins, but it also regulates proliferation, cell cycle, and maturation during granulopoiesis. Cebpe(-/-) mice have incomplete granulocytic differentiation and increased sensitivity toward bacterial infections. The amount of C/EBP-epsilon messenger RNA (mRNA) increases with maturation from myeloblasts with peak level in myelocytes (MC)/metamyelocytes (MM), when the cells stop proliferating followed by a decline in more mature cells. In contrast, C/EBP-epsilon protein is virtually detectable only in the MC/MM population, indicating that expression in more immature cells could be inhibited by microRNAs (miRNAs). We found that miRNA-130a (miR-130a) regulates C/EBP-epsilon protein expression in both murine and human granulocytic precursors. Overexpression of miR-130a in a murine cell line downregulated C/EBP-epsilon protein and lactoferrin (Ltf), cathelicidin antimicrobial protein (Camp), and lipocalin-2 (Lcn2) mRNA expression giving rise to cells with a more immature phenotype, as seen in the Cebpe(-/-) mouse. Introduction of a C/EBP-epsilon mRNA without target site for miR-130a restored both C/EBP-epsilon production, expression of Camp and Lcn2, and resulted in the cells having a more mature phenotype. We conclude that miR-130a is important for the regulation of the timed expression of C/EBP-epsilon during granulopoiesis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

0 Bio Entities

0 Expression